Pursuant to Regulation 29 read with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, IPCA Laboratories has informed that a meeting of the Board of Directors of the Company will be held on Wednesday, 14th February, 2024, to consider and take on record the Standalone and Consolidated Unaudited Financial Results for the 3rd quarter and nine months ended 31st December, 2023. Further, with reference to the above meeting of the Board of Directors, they have already informed vide its letter dated 21st December, 2023 that the trading window for dealing in the securities of the Company by the Insiders as defined under the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed with immediate effect and until 48 hours after the declaration of the Company’s unaudited financial results for the 3rd quarter and nine months ended 31st December, 2023 of the financial year 2023-24, i.e., till 16th February, 2024.
The above information is a part of company’s filings submitted to BSE.